3 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18269837 | NRF2-ACTIVATING COMPOUND | KIFLE, BRUCK | 1624 | Final Rejection | Jun 27, 2023 |
| 17831843 | THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM | SCHMITT, MICHAEL J | 1629 | Final Rejection | Jun 03, 2022 |
| 17610844 | COMPOSITION FOR PREVENTING OR TREATING NEUROTROPHIC KERATITIS WHICH CONTAINS PACAP PEPTIDE OR STABILIZED PACAP PEPTIDE | STEELE, AMBER D | 1658 | Non-Final OA | Nov 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial